NVS240719C100000
- 6.23
- -1.12-15.24%
Novartis AG Newsroom
Analysts' Opinions Are Mixed on These Healthcare Stocks: Novartis AG (Six Swiss: CH:NOVN), Biogen (BIIB) and Sartorius (GB:0NIR)
Novartis AG (NOVN) Gets a Buy From Kepler Capital
Ionis (IONS) Completes Enrolment for Rare Disease Drug Study
Pharma Stock Roundup: JNJ, NVS Q2 Earnings, RHHBY's Positive Obesity Pill Data
Express News | Novartis AG : BMO Raises Target Price to $118 From $116
Analysts Offer Insights on Healthcare Companies: Novartis AG (Six Swiss: CH:NOVN), Moderna (MRNA) and Argenx Se (ARGX)
Deutsche Numis Downgrades Novartis AG (NOVN) to a Hold
Novartis Cut to Hold From Buy by Deutsche Bank
Novartis Cut to Hold From Buy by Deutsche
Novartis Target Cut to CHF105 From CHF110 by Deutsche Bank
Novartis Target Cut to CHF105 From CHF110 by Deutsche
Barclays Keeps Their Sell Rating on Novartis AG (NOVN)
Top Gap Ups and Downs on Thursday: NVS, PGR, INFY and More
Gaps can show signals that something important has happened to the fundamental or the psychology of traders that accompanies this market movement.
Novartis' Q2 Earnings: Revenue And EPS Beat, Raises 2024 Profit Forecast On Strong Demand For Key Drugs
Swiss pharma giant Novartis AG (NYSE:NVS) reported a second-quarter adjusted EPS of $1.97, up 21% year over year (+17% on constant currency), beating the consensus of $1.89.The company's sales
Novartis (NVS) Tops on Q2 Earnings, Ups Operating Income View
All growth rates mentioned below are on a year-over-year basis and at constant exchange rates.
Exchange-Traded Funds Higher, Equity Futures Mixed Pre-Bell Thursday as Tech Stocks Recover
The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was up 0.3% and the actively traded Invesco QQQ Trust (QQQ) was 0.6% higher in Thursday's premarket activity, as tech stocks
Novartis Shares Are Trading Lower. The Company Reported Q2 Financial Results.
Novartis Shares Are Trading Lower. The Company Reported Q2 Financial Results.
Trending: Novartis Raises Profit Guidance as It Prepares for Patent Expirations
1137 GMT - Novartis is among the most mentioned companies across news items over the past 10 hours, according to Factiva data. The Swiss pharma company raised its profit guidance for a second time
Stocks Mostly Up Pre-Bell as Investors Await More Earnings; Asia Churns, Europe Down
The benchmark US stock measures were mostly pointing higher before Thursday's opening bell as traders brace for another round of corporate earnings.Standard & Poor's 500 edged up 0.1% and the Nasdaq
Novartis Q2 Core Earnings, Revenue Advance; 2024 Outlook Updated
Novartis (NVS) reported Q2 core earnings Thursday of $1.97 per diluted share, up from $1.67 a year earlier.
Novartis Raises FY Profit Guidance After Strong Quarter
Novartis (SIX:NOVN) raised its profit guidance Thursday, as the Swiss drugmaker reported second-quarter profit and sales ahead of expectations, boosted by revenue from its blockbuster treatments.
Buy Rating for Novartis AG on Robust Earnings and Promising Growth Outlook